Helix, a joint venture between Illumina, Warburg Pincus and Sutter Hill Ventures, aims to accelerate the consumer adoption of genomics.
UK study reports that pinpointing the exact genetic causes of diabetes is revolutionising patient care.
Dean Schorno, former CFO of Adaptive Technologies Corp, joins 23andMe amid plans to relaunch health-focused products.
Reprogramming damaged retinal cells to detect light again could form basis of a general gene-therapy for blindness.
Using GM yeast cells as miniature drug factories could dramatically reduce costs and improve the stability of drug manufacture.
New BBC radio series FutureProofing explores the impact of synthetic biology, with input from Jennifer Doudna and Craig Venter
Vanderbilt University survey clinicians on pharmacogenomic attitudes It’s often said that the biggest barrier to integrating genomics into routine healthcare, is healthcare itself. There are doubts over how well equipped clinicians are to manage genomic data, or act on genomic test results. If you’ve been to any of the big conferences this summer, you’ve likely […]
Research coming out of Stanford University School of Medicine promises better way to identify genetic defects in heart patients.
New report shows that UK is strongly positioned to be a key player in translational gene therapy research.
Researchers at Cincinnati Children’s Hospital Medical Center have developed BioWardrobe, a user-friendly, platform for analyzing genomic big data.
New Centre for Precision Genomics at The Jackson Laboratory aims to find solutions to life-threatening and genetically complex human diseases.
New targets identified as our understanding of Huntington’s disease increases
Editas Medicine raises more funds to develop CRISPR-Cas9 for clinical application.
The Week in Genomics: how genes and politics mix, new funding for genomics startups, and whether we should be editing DNA in wildlife or not.
Researchers hope that finding will make genetic testing a standard part of treating a child with cerebral palsy.